Cdk1/cyclin B, active

C-terminal 6His-tagged recombinant, human full length cdk1, and N-terminal GST-tagged human full length cyclin B.

Catalog #: 14-450

$359.00$2,889.00


Inquire
Biological Information
Background Information:
The cyclin-dependent kinases (CDKs), a subfamily of protein kinases, promote cell cycle progression. In mammals, nine different CDKs (cdk 1 to cdk 9; cdk 1 is better known as cdc 2) have been identified. CDKs are regulated on various levels including binding of proteins (cyclins, inhibitors, and assembly factors), protein degradation, transcriptional control, localization, and multiple phosphorylations. This leads to timely regulation of CDK activity, allowing progression from one cell cycle phase to the next. The cdk1 induces entry into M-phase of the cell cycle in eukaryotes. GenBank NM_001786 / EMBL M25753
Target Class:
Kinase
Family:
Serine/Threonine Kinase: CDK1 subfamily
Accession Number:
NM_001786.2; NM_033379.2
Target Name:
CDK1/cyclinB
Target Aliases:
CDC2CDK1MGC111195DKFZp686L20222CDC28A
Target Species:
Human
Usage
Product Type:
Enzymes
Application:
Drug Discovery & Development
Storage Conditions:
6 months at -70°C
Usage Disclaimer:
These products may be covered by issued US and/or foreign patents, patent application and subject to Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information.

Datasheets

14-450x Datasheet

View Document